HDAC9 and ischemic stroke: Although significant progress has been made in understanding the pathogenesis and treatment of HDAC inhibitors in cerebral ischemia-reperfusion injury from preclinical studies, clinical studies of HDAC inhibitors in ischemic stroke patients are limited.